SERPING1 and familial pancreatic carcinoma: org, Pathology atlas [9] (https://www.proteinatlas.org/ENSG00000149131-SERPING1/pathology) showed that 5-year survival was 15% in patients with pancreatic cancer and high expression of Serping 1 (C1-INH), whereas those with a low expression had a 5-year survival of 56% (p-score 0.0059) (Figure 7).